Bristol-Myers Squibb Co (BMY)
45.08
-3.78
(-7.74%)
USD |
NYSE |
Apr 25, 10:59
Bristol-Myers Squibb Revenue (Quarterly): 11.48B for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.48B |
| September 30, 2023 | 10.97B |
| June 30, 2023 | 11.23B |
| March 31, 2023 | 11.34B |
| December 31, 2022 | 11.41B |
| September 30, 2022 | 11.22B |
| June 30, 2022 | 11.89B |
| March 31, 2022 | 11.65B |
| December 31, 2021 | 11.98B |
| September 30, 2021 | 11.62B |
| June 30, 2021 | 11.70B |
| March 31, 2021 | 11.07B |
| December 31, 2020 | 11.07B |
| September 30, 2020 | 10.54B |
| June 30, 2020 | 10.13B |
| March 31, 2020 | 10.78B |
| December 31, 2019 | 7.945B |
| September 30, 2019 | 6.007B |
| June 30, 2019 | 6.273B |
| March 31, 2019 | 5.92B |
| December 31, 2018 | 5.973B |
| September 30, 2018 | 5.691B |
| June 30, 2018 | 5.704B |
| March 31, 2018 | 5.193B |
| December 31, 2017 | 5.449B |
| Date | Value |
|---|---|
| September 30, 2017 | 5.254B |
| June 30, 2017 | 5.144B |
| March 31, 2017 | 4.929B |
| December 31, 2016 | 5.243B |
| September 30, 2016 | 4.922B |
| June 30, 2016 | 4.871B |
| March 31, 2016 | 4.391B |
| December 31, 2015 | 4.287B |
| September 30, 2015 | 4.069B |
| June 30, 2015 | 4.163B |
| March 31, 2015 | 4.041B |
| December 31, 2014 | 4.258B |
| September 30, 2014 | 3.921B |
| June 30, 2014 | 3.889B |
| March 31, 2014 | 3.811B |
| December 31, 2013 | 4.441B |
| September 30, 2013 | 4.065B |
| June 30, 2013 | 4.048B |
| March 31, 2013 | 3.831B |
| December 31, 2012 | 4.191B |
| September 30, 2012 | 3.736B |
| June 30, 2012 | 4.443B |
| March 31, 2012 | 5.251B |
| December 31, 2011 | 5.454B |
| September 30, 2011 | 5.345B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
6.007B
Minimum
Sep 2019
11.98B
Maximum
Dec 2021
10.54B
Average
11.22B
Median
Sep 2022
Revenue (Quarterly) Benchmarks
| Amgen Inc | 8.196B |
| Gilead Sciences Inc | 7.114B |
| Johnson & Johnson | 21.38B |
| Karuna Therapeutics Inc (DELISTED) | -- |
| 2seventy bio Inc | 10.68M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.762B |
| Total Expenses (Quarterly) | 9.574B |
| EPS Diluted (Quarterly) | 0.87 |
| Enterprise Value | 126.35B |
| Gross Profit Margin (Quarterly) | 76.08% |
| Profit Margin (Quarterly) | 15.35% |
| Earnings Yield | 8.56% |
| Operating Earnings Yield | 8.75% |
| Normalized Earnings Yield | 8.406 |